| Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study. |
26319120 |
Breast Cancer Res Treat |
| Dermcidin expression is associated with disease progression and survival among breast cancer patients. |
24562771 |
Breast Cancer Res Treat |
| Designing early detection programs for ovarian cancer. |
22180403 |
Ann Oncol |
| Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study. |
22903690 |
Breast Cancer Res Treat |
| Discovery of novel plasma proteins as biomarkers for the development of incisional hernias after midline incision in patients with colorectal cancer: The ColoCare study. |
27745870 |
Surgery |
| Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility? |
27001493 |
Clin Chem |
| Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125. |
22155417 |
Gynecol Oncol |
| Identifying post-menopausal women at elevated risk for epithelial ovarian cancer. |
26343159 |
Gynecol Oncol |
| Immunity to placental malaria. III. Impairment of interleukin(IL)-12, not IL-18, and interferon-inducible protein-10 responses in the placental intervillous blood of human immunodeficiency virus/malaria-coinfected women. |
11756993 |
J Infect Dis |
| Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening. |
22750949 |
Cancer Prev Res (Phila) |
| Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer. |
22962406 |
Cancer Epidemiol Biomarkers Prev |
| JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors. |
24764577 |
Cancer Immunol Res |
| Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule. |
23248253 |
J Clin Oncol |
| Potential role of HE4 in multimodal screening for epithelial ovarian cancer. |
21917606 |
J Natl Cancer Inst |
| Protein and glycomic plasma markers for early detection of adenoma and colon cancer. |
27821646 |
Gut |
| Proteomic Analysis, Immune Dysregulation, and Pathway Interconnections with Obesity. |
27769113 |
J Proteome Res |
| Recommendation to use exact P-values in biomarker discovery research in place of approximate P-values. |
30099328 |
Cancer Epidemiol |
